---
schema_version: "secwatch.filing_event.v1"
accession: "0000021076-25-000051"
form_type: "8-K"
ticker: "CLX"
cik: "0000021076"
company_name: "CLOROX CO /DE/"
filed_at: "2025-11-03T23:59:59+00:00"
generated_at: "2026-05-17T00:58:24.615362+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clorox Q1 FY2026: Net sales down 19% to $1.43B, adj. EPS $0.85 (-54% YoY) on ERP disruption

## Summary
- Diluted EPS $0.65 vs $0.80 prior year; adjusted EPS $0.85 vs $1.86 (-54%), largely due to ERP transition.
- Gross margin fell 410 bps to 41.7% on lower volume and higher manufacturing/logistics costs.
- Organic sales declined 17%, with volume down 15%; Health & Wellness segment sales -19%.
- Operating cash flow $93M vs $221M (-58%); free cash flow $57M vs $182M.
- Company cites expected ERP transition impact; no specific numerical guidance revision provided.

## SEC filing metadata
- accession: 0000021076-25-000051
- form_type: 8-K
- ticker: CLX
- cik: 0000021076
- company_name: CLOROX CO /DE/
- filed_at: 2025-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/21076/000002107625000051/0000021076-25-000051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/21076/000002107625000051/clx-20251103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000021076-25-000051
- JSON: https://secwatch.observer/filing/0000021076-25-000051.json
- Plain text: https://secwatch.observer/filing/0000021076-25-000051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.